Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IOngoingD-0094-2026

Drug recall · October 15, 2025

NAD+ (Nicotinamide adenine dinucleotide) for Injection recall

Why: Microbial Contamination of Sterile Products: elevated endotoxin levels

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

NAD+ (Nicotinamide adenine dinucleotide) for Injection, a) 100 mg/mL b) 200 mg/mL, 10 mL multi-dose amber vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

Lots / codes

Lot#: GG121624-023, within expiry

Company
GenoGenix LLC, Boca Raton, FL
Distribution
US Nationwide.
Initiated
July 30, 2025 · Voluntary: Firm initiated
Classified
October 21, 2025
Reported
October 15, 2025
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.